
Late-breaking advances in AI-enabled drug discovery, including news, research progress, market trends, and interviews
| Publishes | Weekly | Episodes | 57 | Founded | a year ago |
|---|---|---|---|---|---|
| Number of Listeners | Categories | NewsTech News | |||

These sources present a framework for transitioning from vague notions of "trusting" artificial intelligence in drug discovery toward a more rigorous system of calibrated reliance. Both documents emphasize that AI reliability must be evaluated within... more
In this episode, we explore the unique ethical landscape of AI-driven drug discovery, which extends beyond traditional data privacy to encompass the entire pharmaceutical lifecycle. Key challenges include algorithmic bias in genomic data, the opacity... more
In this episode, we explore the evolving landscape of AI-driven pharmaceutical intellectual property, emphasizing that, for patent offices, artificial intelligence is viewed as a computational tool rather than an inventor. Effective legal strategies ... more
In this episode, we outline the critical role of biomarkers and companion diagnostics (CDx) in advancing personalized medicine and streamlining drug discovery. It details how germline genetic variations help prevent adverse reactions, while somatic m... more
People also subscribe to these shows.




I have no domain expertise and yet I could easily understand this episode! Absolutely well executed and offers a brilliant primer and insights
I have no domain expertise and yet I could easily understand this episode! Absolutely well executed and offers a brilliant primer and insights
Experienced hosts, well researched and excellent way to come to all levels of audiences. Very engaging and enlightening
Experienced hosts, well researched and excellent way to come to all levels of audiences. Very engaging and enlightening
How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.
Apple Podcasts | #214 | |
Apple Podcasts | #231 | |
Apple Podcasts | #68 | |
Apple Podcasts | #125 | |
Apple Podcasts | #148 | |
Apple Podcasts | #150 |
Recent interactions between the hosts and their guests.
Listeners, social reach, demographics and more for this podcast.
| Listeners per Episode | |
|---|---|
| Gender Skew | |
| Location | |
| Interests | |
| Professions | |
| Age Range | |
| Household Income | |
| Social Media Reach |
The episodes center on AI-enabled drug discovery and its evolving ecosystem, from how AI reshapes early-stage research and screening to the strategic implications for patents, regulatory pathways, and market dynamics. Across episodes, discussions frequently rotate between technical advances (benchmarking AI in drug discovery, autonomous lab concepts, and next-generation design engines) and practical implications for industry players (pharma, biotech startups, and investors). A standout thread is the tension between hype and real-world impact, with careful attention to risk factors like data bias, regulatory considerations, ethical questions around in silico trials, and the economics of AI-driven platforms versus traditional models. The show... more
Rephonic provides a wide range of podcast stats for Drug Discovery AI Talk. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Drug Discovery AI Talk and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Drug Discovery AI Talk, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
Rephonic provides comprehensive predictive audience data for Drug Discovery AI Talk, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
To see how many followers or subscribers Drug Discovery AI Talk has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
These podcasts share a similar audience with Drug Discovery AI Talk:
1. Biotech Hangout
2. All-In with Chamath, Jason, Sacks & Friedberg
3. The Daily
4. Up First from NPR
5. ASGCT Podcast Network
Drug Discovery AI Talk launched a year ago and published 57 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Rephonic pulls ratings and reviews for Drug Discovery AI Talk from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
Rephonic provides full transcripts for episodes of Drug Discovery AI Talk. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.
Recent guests on Drug Discovery AI Talk include:
1. Adam Wise
2. Alex Zebronkov
3. Jake Chen
4. Dr. Peter Lee
5. Dr. John Brownstein
6. Dr. Timothy Yu
7. Dr. Catherine Wu
8. Dr. Manika Balasagaram
To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.